Acadia Healthcare (ACHC) Stock Forecast, Price Target & Predictions
ACHC Stock Forecast
Acadia Healthcare stock forecast is as follows: an average price target of $81.50 (represents a 86.33% upside from ACHC’s last price of $43.74) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
ACHC Price Target
The average price target for Acadia Healthcare (ACHC) is $81.50 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $87.00 to $76.00. This represents a potential 86.33% upside from ACHC's last price of $43.74.
ACHC Analyst Ratings
According to 9 Wall Street analysts, Acadia Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for ACHC stock is 0 'Strong Buy' (0.00%), 6 'Buy' (66.67%), 3 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Acadia Healthcare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 21, 2024 | Whit Mayo | Leerink Partners | $87.00 | $52.03 | 67.21% | 98.90% |
| Sep 27, 2024 | Andrew Mok | Barclays | $76.00 | $63.87 | 18.99% | 73.75% |
| Aug 01, 2024 | Andrew Mok | Barclays | $83.00 | $64.85 | 27.99% | 89.76% |
| May 22, 2024 | Frank Morgan | RBC Capital | $94.00 | $66.64 | 41.06% | 114.91% |
| May 03, 2024 | Ann Hynes | Mizuho Securities | $70.00 | $66.73 | 4.90% | 60.04% |
| Apr 25, 2024 | Pito Chickering | Deutsche Bank | $70.00 | $71.19 | -1.67% | 60.04% |
| Dec 12, 2022 | RBC Capital | $93.00 | $82.25 | 13.07% | 112.62% | |
| Aug 26, 2022 | Leerink Partners | $103.00 | $85.23 | 20.85% | 135.48% | |
| Aug 01, 2022 | RBC Capital | $94.00 | $82.91 | 13.38% | 114.91% | |
| Aug 01, 2022 | Raymond James | $100.00 | $82.91 | 20.61% | 128.62% | |
| Jul 29, 2022 | Mizuho Securities | $78.00 | $80.91 | -3.59% | 78.33% | |
| Jul 29, 2022 | Barclays | $85.00 | $80.93 | 5.03% | 94.33% | |
| Jul 28, 2022 | UBS | $90.00 | $79.94 | 12.58% | 105.76% | |
| Jun 20, 2022 | Joseph France | Loop Capital Markets | $72.00 | $64.90 | 10.94% | 64.61% |
| May 05, 2022 | Leerink Partners | $95.00 | $70.65 | 34.47% | 117.19% | |
| May 05, 2022 | Raymond James | $85.00 | $71.57 | 18.76% | 94.33% | |
| Aug 03, 2021 | Kevin Fischbeck | Bank of America Securities | $82.00 | $63.62 | 28.89% | 87.47% |
The latest Acadia Healthcare stock forecast, released on Oct 21, 2024 by Whit Mayo from Leerink Partners, set a price target of $87.00, which represents a 67.21% increase from the stock price at the time of the forecast ($52.03), and a 98.90% increase from ACHC last price ($43.74).
Acadia Healthcare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 6 |
| Avg Price Target | - | - | $80.00 |
| Last Closing Price | $43.74 | $43.74 | $43.74 |
| Upside/Downside | -100.00% | -100.00% | 82.90% |
In the current month, the average price target of Acadia Healthcare stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Acadia Healthcare's last price of $43.74. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 21, 2024 | Leerink Partners | Outperform | Outperform | Hold |
| Oct 11, 2024 | RBC Capital | Hold | Hold | Hold |
| Oct 11, 2024 | Raymond James | Underperform | Underperform | Hold |
| Oct 10, 2024 | KeyBanc | Sector Weight | Initialise | |
| Sep 27, 2024 | Barclays | Overweight | Overweight | Hold |
| Sep 20, 2024 | RBC Capital | Hold | Hold | Hold |
| Sep 20, 2024 | Raymond James | Underperform | Underperform | Hold |
| Aug 19, 2024 | RBC Capital | Hold | Hold | Hold |
| Aug 02, 2024 | Raymond James | Underperform | Underperform | Hold |
| Aug 02, 2024 | RBC Capital | Buy | Buy | Hold |
| Aug 01, 2024 | Barclays | Overweight | Overweight | Hold |
| Jul 02, 2024 | Mizuho Securities | Underperform | Underperform | Hold |
| Jul 02, 2024 | RBC Capital | Buy | Buy | Hold |
| Jun 18, 2024 | Cowen & Co. | Buy | Buy | Hold |
| May 22, 2024 | RBC Capital | Outperform | Outperform | Hold |
| May 17, 2024 | UBS | Buy | Buy | Hold |
| May 17, 2024 | RBC Capital | Underperform | Underperform | Hold |
| May 07, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Apr 25, 2024 | Deutsche Bank | Hold | Upgrade | |
| Mar 04, 2024 | Stephens | Underperform | Underperform | Hold |
| Mar 04, 2024 | UBS | Buy | Buy | Hold |
| Jan 05, 2024 | Stephens | Overweight | Upgrade | |
| Dec 12, 2022 | RBC Capital | Outperform | Outperform | Hold |
| Dec 12, 2022 | Loop Capital Markets | Hold | Buy | Upgrade |
| Aug 26, 2022 | SVB Leerink | Outperform | Outperform | Hold |
| Aug 01, 2022 | RBC Capital | Outperform | Outperform | Hold |
| Aug 01, 2022 | Raymond James | Strong Buy | Strong Buy | Hold |
| Jul 29, 2022 | Barclays | Underweight | Underweight | Hold |
| Jul 28, 2022 | UBS | Buy | Buy | Hold |
| Jun 16, 2022 | Loop Capital Markets | Hold | Initialise |
Acadia Healthcare's last stock rating was published by Leerink Partners on Oct 21, 2024. The company gave ACHC a "Outperform" rating, the same as its previous rate.
Acadia Healthcare Financial Forecast
Acadia Healthcare Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $742.80M | $750.33M | $731.34M | $704.27M | $675.29M | $666.73M | $651.72M | $616.65M | $593.48M | $587.56M | $582.16M | $551.20M | $541.28M | $833.30M | $750.31M | $782.81M | $780.23M | $777.25M |
| Avg Forecast | $942.37M | $966.62M | $939.99M | $902.40M | $867.16M | $888.32M | $859.21M | $822.62M | $779.69M | $819.42M | $785.73M | $779.17M | $727.60M | $726.23M | $711.92M | $689.62M | $660.39M | $657.50M | $650.82M | $606.52M | $588.00M | $591.41M | $560.76M | $544.71M | $826.97M | $800.25M | $763.07M | $793.23M | $780.27M | $790.48M |
| High Forecast | $957.34M | $981.97M | $954.91M | $916.73M | $880.93M | $902.43M | $872.86M | $830.66M | $782.81M | $819.64M | $786.40M | $779.18M | $732.83M | $726.24M | $723.22M | $700.58M | $668.94M | $657.50M | $650.82M | $606.52M | $588.00M | $591.41M | $560.76M | $544.71M | $826.97M | $800.25M | $763.07M | $793.23M | $780.27M | $790.48M |
| Low Forecast | $923.03M | $946.78M | $920.69M | $883.88M | $849.36M | $870.09M | $841.58M | $806.47M | $775.28M | $819.20M | $785.05M | $779.15M | $723.49M | $726.23M | $697.31M | $675.47M | $648.59M | $657.50M | $650.82M | $606.52M | $588.00M | $591.41M | $560.76M | $544.71M | $826.97M | $800.25M | $763.07M | $793.23M | $780.27M | $790.48M |
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 9 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 9 | 8 | 7 | 6 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.03% | 1.03% | 1.02% | 1.02% | 1.01% | 1.00% | 1.02% | 1.01% | 0.99% | 1.04% | 1.01% | 0.65% | 1.04% | 0.98% | 0.99% | 1.00% | 0.98% |
Acadia Healthcare's average Quarter revenue forecast for Mar 24 based on 4 analysts is $779.17M, with a low forecast of $779.15M, and a high forecast of $779.18M. ACHC's average Quarter revenue forecast represents a 4.90% increase compared to the company's last Quarter revenue of $742.80M (Dec 23).
Acadia Healthcare EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 9 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 9 | 8 | 7 | 6 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $133.79M | $-235.45M | $148.10M | $137.21M | $137.62M | $144.68M | $155.35M | $124.03M | $143.75M | $127.05M | $106.18M | $69.84M | $-755.98M | $124.63M | $129.47M | $123.72M | $74.29M | $136.67M |
| Avg Forecast | $153.95M | $157.91M | $153.56M | $147.42M | $141.66M | $145.12M | $140.36M | $134.39M | $127.37M | $133.86M | $128.36M | $141.80M | $118.86M | $118.64M | $116.30M | $128.91M | $160.46M | $139.65M | $138.24M | $117.19M | $124.89M | $125.62M | $119.11M | $66.74M | $175.65M | $169.97M | $162.08M | $110.69M | $165.73M | $167.90M |
| High Forecast | $156.39M | $160.42M | $156.00M | $149.76M | $143.91M | $147.42M | $142.59M | $135.70M | $127.88M | $133.90M | $128.47M | $170.16M | $119.72M | $118.64M | $118.15M | $154.69M | $192.55M | $139.65M | $138.24M | $140.63M | $124.89M | $125.62M | $119.11M | $80.09M | $175.65M | $169.97M | $162.08M | $132.83M | $165.73M | $167.90M |
| Low Forecast | $150.79M | $154.67M | $150.41M | $144.39M | $138.75M | $142.14M | $137.48M | $131.75M | $126.65M | $133.83M | $128.25M | $113.44M | $118.19M | $118.64M | $113.91M | $103.13M | $128.36M | $139.65M | $138.24M | $93.75M | $124.89M | $125.62M | $119.11M | $53.39M | $175.65M | $169.97M | $162.08M | $88.56M | $165.73M | $167.90M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | -1.98% | 1.27% | 1.06% | 0.86% | 1.04% | 1.12% | 1.06% | 1.15% | 1.01% | 0.89% | 1.05% | -4.30% | 0.73% | 0.80% | 1.12% | 0.45% | 0.81% |
4 analysts predict ACHC's average Quarter EBITDA for Mar 24 to be $141.80M, with a high of $170.16M and a low of $113.44M. This is 5.98% upper than Acadia Healthcare's previous annual EBITDA (Dec 23) of $133.79M.
Acadia Healthcare Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 9 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 9 | 8 | 7 | 6 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $57.73M | $-217.71M | $72.30M | $66.02M | $61.12M | $71.10M | $80.08M | $60.84M | $71.52M | $66.13M | $44.51M | $9.72M | $-783.67M | $37.00M | $41.08M | $33.46M | $-11.25M | $42.57M |
| Avg Forecast | $86.54M | $96.10M | $93.33M | $80.80M | $73.53M | $86.71M | $82.59M | $70.62M | $66.30M | $82.92M | $80.79M | $70.16M | $73.07M | $82.22M | $79.06M | $63.78M | $83.94M | $72.36M | $71.61M | $57.99M | $62.87M | $66.65M | $57.87M | $9.29M | $58.49M | $49.47M | $35.63M | $29.94M | $45.36M | $50.89M |
| High Forecast | $88.33M | $98.09M | $95.25M | $82.47M | $75.05M | $88.51M | $84.29M | $82.70M | $68.15M | $83.08M | $81.08M | $84.19M | $75.81M | $82.31M | $80.70M | $76.54M | $100.73M | $72.36M | $71.61M | $69.58M | $62.87M | $66.65M | $57.87M | $11.14M | $58.49M | $49.47M | $35.63M | $35.93M | $45.36M | $50.89M |
| Low Forecast | $84.23M | $93.54M | $90.84M | $78.65M | $71.57M | $84.40M | $80.38M | $61.33M | $64.46M | $82.75M | $80.50M | $56.13M | $70.33M | $82.13M | $76.95M | $51.03M | $67.15M | $72.36M | $71.61M | $46.39M | $62.87M | $66.65M | $57.87M | $7.43M | $58.49M | $49.47M | $35.63M | $23.95M | $45.36M | $50.89M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.79% | -2.65% | 0.91% | 1.03% | 0.73% | 0.98% | 1.12% | 1.05% | 1.14% | 0.99% | 0.77% | 1.05% | -13.40% | 0.75% | 1.15% | 1.12% | -0.25% | 0.84% |
Acadia Healthcare's average Quarter net income forecast for Mar 24 is $70.16M, with a range of $56.13M to $84.19M. ACHC's average Quarter net income forecast represents a 21.54% increase compared to the company's last Quarter net income of $57.73M (Dec 23).
Acadia Healthcare SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 9 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 9 | 8 | 7 | 6 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $45.55M | $45.54M | $43.80M | $52.55M | $51.98M | $51.71M | $51.63M | $48.16M | $6.13M | $45.26M | $44.32M | $41.03M | $-88.25M | $82.54M | $79.44M | $524.44M | $513.54M | $510.89M |
| Avg Forecast | $74.13M | $76.04M | $73.94M | $70.98M | $68.21M | $69.88M | $67.59M | $64.71M | $61.33M | $64.46M | $61.81M | $55.54M | $57.23M | $57.13M | $56.00M | $50.49M | $6.85M | $51.72M | $51.19M | $45.90M | $46.25M | $46.52M | $44.11M | $39.21M | $65.05M | $62.95M | $60.03M | $469.24M | $61.38M | $62.18M |
| High Forecast | $75.31M | $77.24M | $75.12M | $72.11M | $69.30M | $70.99M | $68.66M | $65.34M | $61.58M | $64.47M | $61.86M | $66.65M | $57.65M | $57.13M | $56.89M | $60.59M | $8.22M | $51.72M | $51.19M | $55.08M | $46.25M | $46.52M | $44.11M | $47.05M | $65.05M | $62.95M | $60.03M | $563.08M | $61.38M | $62.18M |
| Low Forecast | $72.61M | $74.48M | $72.42M | $69.53M | $66.81M | $68.44M | $66.20M | $63.44M | $60.99M | $64.44M | $61.75M | $44.43M | $56.91M | $57.13M | $54.85M | $40.39M | $5.48M | $51.72M | $51.19M | $36.72M | $46.25M | $46.52M | $44.11M | $31.36M | $65.05M | $62.95M | $60.03M | $375.39M | $61.38M | $62.18M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.80% | 0.80% | 0.78% | 1.04% | 7.59% | 1.00% | 1.01% | 1.05% | 0.13% | 0.97% | 1.00% | 1.05% | -1.36% | 1.31% | 1.32% | 1.12% | 8.37% | 8.22% |
Acadia Healthcare's average Quarter SG&A projection for Mar 24 is $55.54M, based on 4 Wall Street analysts, with a range of $44.43M to $66.65M. The forecast indicates a 21.95% rise compared to ACHC last annual SG&A of $45.55M (Dec 23).
Acadia Healthcare EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 8 | 9 | 4 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 9 | 8 | 7 | 6 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.63 | $-2.39 | $0.79 | $0.73 | $0.68 | $0.79 | $0.89 | $0.68 | $0.80 | $0.74 | $0.50 | $0.11 | $-8.91 | $0.42 | $0.47 | $0.38 | $-0.13 | $0.49 |
| Avg Forecast | $0.94 | $1.04 | $1.01 | $0.88 | $0.80 | $0.94 | $0.90 | $0.77 | $0.72 | $0.90 | $0.88 | $0.80 | $0.79 | $0.89 | $0.86 | $0.71 | $0.75 | $0.79 | $0.78 | $0.64 | $0.68 | $0.72 | $0.63 | $0.44 | $0.64 | $0.54 | $0.39 | $0.38 | $0.49 | $0.55 |
| High Forecast | $0.96 | $1.06 | $1.03 | $0.89 | $0.81 | $0.96 | $0.91 | $0.90 | $0.74 | $0.90 | $0.88 | $0.80 | $0.82 | $0.89 | $0.88 | $0.72 | $0.76 | $0.79 | $0.78 | $0.64 | $0.68 | $0.72 | $0.63 | $0.44 | $0.64 | $0.54 | $0.39 | $0.38 | $0.49 | $0.55 |
| Low Forecast | $0.91 | $1.01 | $0.99 | $0.85 | $0.78 | $0.92 | $0.87 | $0.67 | $0.70 | $0.90 | $0.87 | $0.80 | $0.76 | $0.89 | $0.83 | $0.69 | $0.73 | $0.79 | $0.78 | $0.64 | $0.68 | $0.72 | $0.63 | $0.44 | $0.64 | $0.54 | $0.39 | $0.38 | $0.49 | $0.55 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.79% | -2.68% | 0.92% | 1.03% | 0.91% | 1.00% | 1.14% | 1.07% | 1.17% | 1.02% | 0.80% | 0.25% | -14.02% | 0.78% | 1.21% | 1.00% | -0.26% | 0.89% |
According to 4 Wall Street analysts, Acadia Healthcare's projected average Quarter EPS for Mar 24 is $0.80, with a low estimate of $0.80 and a high estimate of $0.80. This represents a 26.50% increase compared to ACHC previous annual EPS of $0.63 (Dec 23).
Acadia Healthcare Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| SEM | Select Medical | $19.60 | $40.00 | 104.08% | Buy |
| ACHC | Acadia Healthcare | $43.74 | $81.50 | 86.33% | Buy |
| INNV | InnovAge | $3.73 | $6.80 | 82.31% | Hold |
| AMED | Amedisys | $92.28 | $143.38 | 55.37% | Hold |
| HCA | HCA Healthcare | $327.62 | $413.20 | 26.12% | Buy |
| PNTG | Pennant Group | $27.51 | $34.67 | 26.03% | Buy |
| THC | Tenet Healthcare | $139.37 | $167.67 | 20.31% | Buy |
| ENSG | Ensign Group | $140.58 | $167.33 | 19.03% | Buy |
| ADUS | Addus HomeCare | $126.27 | $146.20 | 15.78% | Buy |
| EHAB | Enhabit | $8.40 | $9.50 | 13.10% | Hold |
| EHC | Encompass Health | $95.57 | $107.50 | 12.48% | Buy |
| OPCH | Option Care Health | $30.95 | $30.33 | -2.00% | Buy |
| DVA | DaVita | $173.77 | $145.00 | -16.56% | Hold |